Kala Pharmaceuticals, Inc. (KALA) Social Stream
KALA BIO INC (KALA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KALA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 7 | $43 | $3.75 | $14.458 | $7.72 | 87.28% |
| 2021-11-16 | 7 | $16 | $2.5 | $7.75 | $7.72 | 0.39% |
| 2021-12-15 | 7 | $9 | $2.5 | $6.083 | $7.72 | -21.2% |
| 2022-03-09 | 7 | $9 | $2.5 | $5.916 | $7.72 | -23.37% |
| 2022-03-30 | 7 | $9 | $2.5 | $5.916 | $7.72 | -23.37% |
| 2022-05-16 | 7 | $6 | $1.75 | $4.458 | $7.72 | -42.25% |
| 2022-05-17 | 7 | $6 | $1.75 | $3.958 | $7.72 | -48.73% |
| 2022-05-23 | 7 | $5 | $1.75 | $3.791 | $7.72 | -50.89% |
| 2022-05-24 | 7 | $4 | $1.75 | $3.125 | $7.72 | -59.52% |
| 2022-08-12 | 3 | $4 | $1.75 | $2.95 | $7.72 | -61.79% |
| 2022-08-15 | 3 | $150 | $87.5 | $115.625 | $7.72 | 1397.73% |
| 2022-11-10 | 3 | $100 | $12 | $61.625 | $7.72 | 698.25% |
| 2023-03-06 | 3 | $87.5 | $12 | $45.875 | $7.72 | 494.24% |
| 2023-03-27 | 3 | $42 | $20 | $33 | $7.72 | 327.46% |
| 2023-04-12 | 3 | $42 | $22 | $33.666 | $7.72 | 336.09% |
| 2023-05-11 | 3 | $42 | $24 | $34.333 | $7.72 | 344.73% |
| 2023-05-22 | 3 | $42 | $24 | $32 | $7.72 | 314.51% |
| 2023-08-11 | 3 | $39 | $24 | $30 | $7.72 | 288.6% |
| 2023-11-14 | 3 | $24 | $15 | $20.333 | $7.72 | 163.38% |
| 2023-11-17 | 3 | $22 | $15 | $19.666 | $7.72 | 154.74% |
The Trend in the Analyst Price Target
Over the past 33 months, KALA's average price target has gone down $1.83.
Over the past 37 weeks, KALA's average upside potential has been 147.24%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-06 | 3 | 87.5 | 20 | 46.625 | 22.34 | 108.71% |
| 2023-03-27 | 3 | 87.5 | 20 | 46.625 | 15.11 | 208.57% |
| 2023-04-12 | 3 | 42.0 | 22 | 33.666 | 17.47 | 92.71% |
| 2023-08-07 | 3 | 39.0 | 24 | 30.000 | 13.42 | 123.55% |
| 2023-11-14 | 3 | 24.0 | 15 | 20.333 | 5.20 | 291.02% |
KALA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 18 months, KALA's average broker recommendation rating improved by 1.14.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- KALA has a greater upside potential (average analyst target price relative to current price) than 1140.88% of all US stocks.
- In the context of stocks in the small market cap category, KALA BIO INC's average analyst price target is higher than 1006.91% of them.
- KALA BIO INC's number of analysts covering the stock is greater than 1161.83% of stocks in the small market cap category.
- KALA BIO INC's variance in analysts' estimates is lower than -1811.68% of stocks in the small market cap category.
Stocks similar to KALA BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATHE, VRNA, and URGN.
View All Top Stocks by Price Target
Is KALA a Buy, Hold or Sell? See the POWR Ratings now!